![]() |
同义名 : | - |
CAS号 : | 20736-09-8 | |
货号 : | A584273 | |
分子式 : | C42H68O13 | |
纯度 : | 98+% | |
分子量 : | 780.98 | |
MDL号 : | N/A | |
存储条件: |
Pure form Sealed in dry, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
描述 | Saikosaponin A (SSA), a main triterpenoid saponin component from Radix Bupleurum, has been revealed to have a variety of pharmacological activities. SSA can suppress angiogenesis and tumor growth by blocking the VEGFR2-mediated signaling pathway[3]. SSa (Saikosaponin A) inhibited IL-1β-induced PGE2 and NO production in a concentration-dependent manner. SSa also suppressed IL-1β-induced MMP1, MMP3, and MMP13 production. Furthermore, SSa significantly attenuated IL-1β-induced phosphorylation levels of NF-κB p65 and IκBα. SSa also up-regulated the expression of LXRα. The inhibition of SSa on PGE2, NO, MMP1, MMP3, and MMP13 production were reversed by LXRα siRNA or GGPP, the inhibitor of LXRα[4]. SSa played a critical anti-inflammatory effect through inhibition of NF-κB and NLRP3 signaling pathways and protected against LPS-induced ALI(acute lung injury)[5]. Saikosaponin A had protective effects against DSS (dextran sulfate sodium)-induced colitis. Saikosaponin A protected DSS-induced colitis through inhibiting inflammatory response[6]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.28mL 0.26mL 0.13mL |
6.40mL 1.28mL 0.64mL |
12.80mL 2.56mL 1.28mL |
参考文献 |
---|